Yellow fever threatens to make a come back

Yellow fever has been written off in the past as a global threat. Yet the failure to eradicate this disease has left the door open for new, large, outbreaks as vaccination of travellers and tropical populations declines, according to an article in the February issue of Microbiology Today magazine from the Society for General Microbiology.

“Yellow fever virus attracts less public attention than, for instance, lassa and ebola, but it remains the greater threat. Containment through effective mosquito control and vaccination of those at risk, including travellers, remains an important though frequently neglected goal,” explains author Dr Philip Mortimer, of the Central Public Health Laboratory, London.

“Today there are few promises of global eradication, and encroachment on tropical forests in South America and West Africa may actually be increasing the danger when populations are not vaccinated,” says Dr Mortimer.

The 17D vaccine for yellow fever, like other types of live attenuated vaccines, carries a remote risk of reversion to the disease-causing form. Not only, therefore, is vaccine protection not being afforded to all the tropical populations who may need it, but its use is now also being questioned among travellers to the Tropics.

“The scientific means exist to keep the global threat of yellow fever under control, but they carry a large financial and possibly a human cost,” says Dr Mortimer.

Media Contact

Tracey Duncombe alphagalileo

More Information:

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

A world-first antibody-drug delivery system

It sounds like the stuff of science fiction: a man-made crystal that can be attached to antibodies and then supercharge them with potent drugs or imaging agents that can seek…

Revealed: How SARS-CoV-2 evades our immune system

Scientists at Hokkaido University and Texas A&M University have identified a key mechanism used by the SARS-CoV-2 virus to evade host immune systems. Researchers in Japan and the United States…

New approach developed to predict response of immunotherapies in lung cancer

New methodology at the University Hospital of Tübingen harnesses the function of platelets. At Tübingen University Hospital, a preclinical study led by Dr. Clemens Hinterleitner and Prof. Dr. Lars Zender,…

Partners & Sponsors